Description

Description

Jardy-Met 12.5/850mg is a fixed-dose combination tablet that brings together a higher strength of Empagliflozin with an increased dose of Metformin, packaged 14 tablets to a pack. Empagliflozin, an SGLT2 inhibitor, helps the kidneys clear excess glucose through urine, while Metformin lowers blood sugar mainly by reducing the liver’s glucose output and improving how effectively the body responds to its own insulin. This particular strength is typically reserved for patients who need both a stronger SGLT2 effect and a higher metformin dose, allowing two more potent components to be delivered together in a single daily tablet rather than as separate medicines.

Ingredients

Each Jardy-Met 12.5/850mg tablet contains:

• Empagliflozin – 12.5 mg
• Metformin Hydrochloride – 850 mg

The tablet also contains standard inactive excipients and a film coating, included only to support the tablet’s structure and ease of swallowing, without any therapeutic effect of their own.

Dosage Form

Jardy-Met 12.5/850mg is manufactured as a film-coated oral tablet, supplied 14 tablets per pack, taken by mouth as directed by a physician.

Uses

Jardy-Met 12.5/850mg is generally prescribed to:

• Improve blood glucose control in adults with type 2 diabetes mellitus who require both a higher Empagliflozin dose and a stronger metformin component
• Continue combination therapy for patients already stabilized on Empagliflozin 12.5mg and metformin 850mg taken as two separate tablets
• Support broader diabetes management goals, including potential cardiovascular and kidney-related benefits, when paired with an appropriate diet and consistent physical activity

It is not suitable for people with type 1 diabetes or for the management of diabetic ketoacidosis.

How to Use

The points below are general guidance only — always follow the specific instructions given by your prescribing doctor:

• Take the tablet with meals, which helps reduce the digestive side effects commonly associated with higher doses of metformin.
• Your doctor will determine the dosing schedule based on your blood sugar control and overall tolerance to both components.
• Swallow the tablet whole with a glass of water; do not crush or chew it, as this can affect how the medicine is absorbed.
• Maintain a consistent daily schedule to help support stable blood sugar management.
• Keep up with scheduled blood tests, including kidney function monitoring, since safe use at this strength depends on adequate kidney health.

Side Effects

Side effects can vary between individuals, but commonly reported ones include:

• Nausea, diarrhea, or general digestive discomfort, particularly during the first few weeks of treatment
• Reduced appetite or a metallic taste in the mouth
• Increased urinary frequency, which may be more noticeable at this higher Empagliflozin dose
• Mild dehydration or increased thirst
• Urinary tract or genital yeast infections

Less commonly, more serious concerns can arise, including a marked drop in blood pressure, lactic acidosis (a rare but serious risk associated with metformin, more likely in those with reduced kidney or liver function), or symptoms suggestive of diabetic ketoacidosis such as ongoing nausea, vomiting, or abdominal pain even when blood glucose readings appear normal. Any of these symptoms warrant urgent medical attention. This is not an exhaustive list, and any unusual or persistent symptom should be reported to a doctor or pharmacist.

Pregnancy & Breastfeeding

Jardy-Met 12.5/850mg is generally not recommended during pregnancy, as the Empagliflozin component may affect fetal kidney development, particularly in later stages of pregnancy, and diabetes control in pregnant women is usually managed through alternative treatment options under specialist care. It is also generally not advised during breastfeeding. Women who are pregnant, planning to become pregnant, or currently breastfeeding should speak with their doctor before starting or continuing this medication.

Storage Instructions

• Store Jardy-Met 12.5/850mg tablets at room temperature, ideally below 25°C, away from direct sunlight, heat, and excess humidity.
• Keep tablets in their original blister packaging until they are needed.
• Store out of the reach of children.
• Do not use tablets past their printed expiry date, and dispose of unused medicine responsibly rather than through household waste.

FAQS

How is the 12.5/850mg strength different from 12.5/500mg?
Both share the same Empagliflozin dose, but this version contains a higher metformin strength, typically chosen for patients who need stronger background glucose control from that component.

Is it necessary to take this tablet with food?
Yes, taking it with a meal is strongly recommended, as it noticeably reduces stomach-related side effects linked to the higher metformin dose.

Will I notice more urination on this strength?
Some patients experience a more pronounced increase in urinary frequency due to the higher Empagliflozin dose, which is generally expected and manageable with adequate fluid intake.

Why does my doctor check my kidney function regularly on this medicine?
Because metformin relies on healthy kidney function to be cleared safely from the body, and the higher Empagliflozin dose also depends on adequate kidney health, so regular monitoring helps ensure the medication remains appropriate.

Can Jardy-Met 12.5/850mg be combined with insulin?
It may sometimes be used alongside insulin under close medical supervision, though this combination increases the risk of low blood sugar and requires careful monitoring.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.